» Articles » PMID: 24442637

A Synthetic Lethal Screen Identifies FAT1 As an Antagonist of Caspase-8 in Extrinsic Apoptosis

Overview
Journal EMBO J
Date 2014 Jan 21
PMID 24442637
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The extrinsic apoptosis pathway is initiated by binding of death ligands to death receptors resulting in the formation of the death-inducing signaling complex (DISC). Activation of procaspase-8 within the DISC and its release from the signaling complex is required for processing executor caspases and commiting cell death. Here, we report that the atypical cadherin FAT1 interacts with caspase-8 preventing the association of caspase-8 with the DISC. We identified FAT1 in a genome-wide siRNA screen for synthetic lethal interactions with death receptor-mediated apoptosis. Knockdown of FAT1 sensitized established and patient-derived glioblastoma cell lines for apoptosis transduced by cell death ligands. Depletion of FAT1 resulted in enhanced procaspase-8 recruitment to the DISC and increased formation of caspase-8 containing secondary signaling complexes. In addition, FAT1 knockout cell lines generated by CRISPR/Cas9-mediated genome engineering were more susceptible for death receptor-mediated apoptosis. Our findings provide evidence for a mechanism to control caspase-8-dependent cell death by the atypical cadherin FAT1. These results contribute towards the understanding of effector caspase regulation in physiological conditions.

Citing Articles

CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review.

Begagic E, Beculic H, duzic N, Dzidic-Krivic A, Pugonja R, Muharemovic A Biomedicines. 2024; 12(1).

PMID: 38275409 PMC: 10813360. DOI: 10.3390/biomedicines12010238.


ELISL: early-late integrated synthetic lethality prediction in cancer.

Tepeli Y, Seale C, Goncalves J Bioinformatics. 2023; 40(1).

PMID: 38113447 PMC: 11616771. DOI: 10.1093/bioinformatics/btad764.


Massive Loss of Transcription Factors Promotes the Initial Diversification of Placental Mammals.

Zhao X, Wu J, Kishino H, Chen L Int J Mol Sci. 2022; 23(17).

PMID: 36077118 PMC: 9456351. DOI: 10.3390/ijms23179720.


Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme.

Al-Sammarraie N, Ray S Cells. 2021; 10(9).

PMID: 34571991 PMC: 8468137. DOI: 10.3390/cells10092342.


Discovering antiviral restriction factors and pathways using genetic screens.

Jones C, Tan W, Grey F, Hughes D J Gen Virol. 2021; 102(5).

PMID: 34020727 PMC: 8295917. DOI: 10.1099/jgv.0.001603.


References
1.
Gyrd-Hansen M, Meier P . IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer. 2010; 10(8):561-74. DOI: 10.1038/nrc2889. View

2.
Gonzalvez F, Lawrence D, Yang B, Yee S, Pitti R, Marsters S . TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. Mol Cell. 2012; 48(6):888-99. DOI: 10.1016/j.molcel.2012.09.031. View

3.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

4.
Gaj T, Gersbach C, Barbas 3rd C . ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 2013; 31(7):397-405. PMC: 3694601. DOI: 10.1016/j.tibtech.2013.04.004. View

5.
Gonzalvez F, Ashkenazi A . New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene. 2010; 29(34):4752-65. DOI: 10.1038/onc.2010.221. View